A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer

~26 mi. (Santiago de Compostela, Spain, +383 more cities)

Complejo Hospitalario Universitario de Santiago (CHUS) ; Servicio de Oncologia

ER Negative, +2 more biomarkers

Breast Carcinoma

atezolizumab, +4 more drugs

chemotherapy, +1 more type

Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)

~26 mi. (Santiago de Compostela, Spain, +147 more cities)

Hosp Clin Univ de Santiago ( Site 0629)

Cervical Adenocarcinoma, +2 more conditions

brachytherapy, +3 more drugs

chemotherapy, +2 more types

Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

~26 mi. (Santiago de Compostela, Spain, +93 more cities)

CHUS - Hospital Clinico Universitario-Servicio de Oncologia ( Site 0660)

Bladder Carcinoma, +1 more condition

cisplatin, +4 more drugs

chemotherapy, +3 more types

Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

~26 mi. (Santiago de Compostela, Spain, +199 more cities)

Complejo Hospitalario Universitario de Santiago ( Site 0668)

Hepatocellular Carcinoma

pembrolizumab

immunotherapy

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

~26 mi. (Santiago de Compostela, Spain, +127 more cities)

Complejo Hospitalario Universitario Santiago de Compostela

BRAF V600E

Colorectal Carcinoma

cetuximab, +3 more drugs

chemotherapy, +1 more type

A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

~26 mi. (Santiago de Compostela, Spain, +172 more cities)

CHUS - Hospital Clinico Universitario

RET Fusion

Non-Small Cell Lung Carcinoma

selpercatinib

targeted therapy

A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy

~26 mi. (Santiago de Compostela, Spain, +260 more cities)

Complejo Hospitalario Universitario de Santiago (CHUS) ; Servicio de Oncologia

ERBB2 Amplification, +1 more biomarker

Invasive Breast Carcinoma

ado-trastuzumab emtansine, +1 more drug

immunotherapy, +1 more type

An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Soc, Versus SoC Alone, in Adult Male Patients With mHSPC

~26 mi. (Santiago de Compostela, Spain, +35 more cities)

Novartis Investigative Site

FOLH1 Expression

Prostate Adenocarcinoma

androgen receptor-directed therapy, +2 more drugs

hormone therapy, +2 more types

Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)

~26 mi. (Santiago de Compostela, Spain, +150 more cities)

Hospital Clinico Universitario de Santiago ( Site 1207)

Head and Neck Squamous Cell Carcinoma

cisplatin, +2 more drugs

chemotherapy, +2 more types

A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab

~26 mi. (Santiago de Compostela, Spain, +81 more cities)

Complejo Hospitalario Universitario de Santiago (CHUS) ; Servicio de Oncologia

Hepatocellular Carcinoma

atezolizumab, +2 more drugs

immunotherapy, +1 more type

A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

~26 mi. (Santiago de Compostela, Spain, +154 more cities)

Complejo Hospitalario Universitario de Santiago (CHUS) ; Servicio de Oncologia

ALK Alternative Transcription Site, +7 more biomarkers

Non-Small Cell Lung Carcinoma

alectinib, +2 more drugs

immunotherapy, +1 more type

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression

~26 mi. (Santiago de Compostela, Spain, +160 more cities)

Hospital Clínico de Santiago

FOLR1 Expression

Fallopian Tube Carcinoma, +2 more conditions

mirvetuximab soravtansine

chemotherapy, +1 more type